| Net Cash Provided by (Used in) Operating Activities |
$7,076,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$14,584,000 |
USD |
-234% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$9,526,000 |
USD |
28% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
49,020,409 |
shares |
18% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,018,000 |
USD |
288% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$10,433,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$15,311,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability |
$591,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Depreciation |
$14,200,000 |
USD |
17% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$841,000 |
USD |
-99% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$208,000 |
USD |
-98% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$204,000 |
USD |
-98% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$120,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$212,000 |
USD |
-97% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$298,000 |
USD |
-33% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
3,359,593 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
4,800,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$217,000 |
USD |
-97% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$1,056,240,000 |
USD |
2.4% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
3,359,593 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$3,909,000 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,606,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$25,175,000 |
USD |
99% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |